Table 1 Patient demographics, indications, technical details, adverse events, and clinical outcomes
Case # | 1 | 2 | 3 |
|---|---|---|---|
Etiology of Cirrhosis | Alcohol | HCV | HCV |
Indication | Portal Hypertension Treatment Prior to Major Abdominal Surgery | Refractory Ascites | Recurrent Hydrothorax |
Child-Pugh Class | B | B | C |
Known PLSVC | No | No | Yes |
Intraoperative Guidance for Portal Vein Access | CO2 Portography | IVUS | IVUS |
Stents Used | Viatorr 12-mm × 6-cm / 2-cm, Wallstent 12-mm × 6-cm | Viatorr 10-mm × 6-cm / 2-cm | Viatorr 8–10-mm × 8-cm / 2-cm |
Pre-TIPS Portosystemic Gradient (mmHg) | 18 | 20 | 12 |
Post-TIPS Portosystemic Gradient (mmHg) | 7 | 4 | 4 |
Fluoroscopy Time (min) | 81.2 | 20.8 | 29.1 |
Radiation Dose (mGy) | 1978 | 506 | 708 |
Technical Success | Yes | Yes | Yes |
Complications | Intraperitoneal Hemorrhage Requiring Transfusion and Angiography (Class D) | None | None |
Revisions | POD 1 for stenosis on angiography | None | POD 31 for elevated velocities on Duplex |
Follow-up Duration (outcome) | 924 days (transplant, lost to follow-up) | 242 days (death) | 363 days (alive with persistent hydrothorax) |